Product logins

Find logins to all Clarivate products below.


Small-Joint Reconstructive Implants – Market Insights – United States

The US small-joint reconstructive implant market will continue to grow steadily, supported by ongoing advancements in implant technology, the increasing adoption of robotic-assisted procedures, and the integration of digital surgical planning tools. Additionally, the continued shift toward outpatient settings and ASCs is improving access to care and contributing to broader market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the US market for small-joint reconstructive implants from 2019 through 2034.

Digital enablement and AI Integration will have a significant impact on the US small-joint reconstructive implant market.

How are AI-powered planning tools influencing surgical outcomes and implant adoption?

Which segments are seeing the highest volume of new product introductions?

How are these innovations impacting ASP trends and market growth?

Reimbursement models and outpatient shifts are reshaping the small-joint market.

How are bundled payment models affecting ASPs and revenue growth?

What impact do CMS reimbursement changes have on procedure volumes and site-of-service shifts?

What factors are driving the continued shift toward outpatient settings and ASCs for small-joint reconstructive procedures?

How are concluding and newly introduced CMS reimbursement policies shaping provider behavior and influencing dynamics across small-joint segments?

The sizable shoulder implant segment continues to exhibit growth.

What factors are contributing to sustained growth in the shoulder arthroplasty market?

Which companies are leading the shoulder implant space, and what innovations are they prioritizing?

Consolidation and acquisitions are reshaping competition in the small-joint implant market.

How has recent consolidation shaped the market, and what share do the remaining competitors hold?

How are leading companies leveraging their positions to maintain market share?

What strategies can emerging competitors adopt to gain traction in this consolidated landscape?

Which product categories offer the most promising opportunities for growth?

Which major companies have made strategic acquisitions to expand their small-joint portfolios and gain market share?

How have these acquisitions reshaped competitive dynamics among existing players?

Table of contents


Related Medtech Insights Reports

Report
Peripheral Vascular Devices – Market Insights – United States
The US PV device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective PV interventions…
Report
Trauma Devices – Market Insights – United States
Long-term growth of the US trauma device market will be driven by the uptake of novel technologies such as 3-D printed implants, the expansion of the foot and ankle device segment, site-of-service…
Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Interventional Oncology Devices – Market Insights – United States
The US market for interventional oncology devices will be driven by the launch and uptake of higher-priced technologies, favorable clinical data, expanding populations that are treatable with…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – United States
The US TEO device market is expected to grow, supported by the approval of new product types within existing indications, entry of new players into different device segments, and favorable changes…